A Study to Evaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC (Non-Small Cell Lung Cancer)
Clinical trial NCT00095225 · COMPLETED
Trial details
- NCT number
- NCT00095225
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-07-01
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.